Company News 2026-09-10
FIMAN Shines at BIOHK 2026, Shaping the Future of Collagen Biotechnology

From September 9–12, BIOHK 2026 Hong Kong International Biotechnology Forum & Exhibition, one of Asia’s most influential biotechnology events, — took place at the Hong Kong Convention and Exhibition Centre. The event brought together leading experts, researchers, and industry leaders from around the world to explore new opportunities in biotechnology and medical innovation.FIMAN presented its two flagship brands, FILLDERM and BIOYONCE, at the event, showcasing the scientific depth and innovative strengths of China’s collagen research to the global aesthetic community.


At the “Manufacturing Beauty — Innovation, Production and Registration of Medical Aesthetics” Forum, chaired by Professor Hongyi Zhao from the Department of Plastic Surgery, Beijing Hospital, President Ju Ning of Shenzhen Mibai Medical Aesthetic Clinic delivered a presentation titled:“Collagen-Based Periorbital Rejuvenation and Strengthening of the Orbicularis Oculi Muscle.”
Drawing on anatomical insights, experimental research, and clinical evidence, the presentation explored a comprehensive approach to periocular rejuvenation. It highlighted the application of FILLDERM Collagen in restoring periorbital structural support and enhancing firmness and elasticity across multiple anatomical layers.

Throughout the event, the FIMAN booth welcomed visitors from China and overseas, with medical professionals and industry guests engaging in discussions around active collagen technology, product innovation, and clinical applications.
The world looks to China for collagen. China looks to FIMAN.BIOHK 2026 marked another important milestone in bringing China’s collagen research and technological innovation to the global stage.
Leveraging its strengths in proprietary research and technological innovation, FIMAN is committed to delivering advanced collagen technologies and clinical insights to the global aesthetic medicine community, while unlocking new possibilities for the international expansion of China’s collagen innovations.



